Organ Recovery Systems

What Organ Recovery Systems does

Organ Recovery Systems, founded in 1998 and headquartered in Itasca, Illinois, is a privately held medical device company specializing in hypothermic machine perfusion (HMP) technology for organ preservation and transplantation. The company's flagship product, the LifePort Kidney Transporter launched in 2003, was the first portable HMP system and has become the clinical standard for kidney preservation, used in over 275,000 procedures across 400+ transplant programs in 49 countries with 98% adoption among US Organ Procurement Organizations (OPOs). The technology platform provides a sealed, sterile, portable environment where physiologic solutions are pumped through kidneys at cold temperatures to minimize ischemic injury during transport, complemented by proprietary consumables including Perfusion Circuits, SealRing Cannulas, KPS-1 (Kidney Perfusion Solution), and SPS-1 (UW-based Static Preservation Solution).

The business model combines capital equipment sales (reusable LifePort devices), high-margin recurring consumables revenue (single-use disposables and preservation solutions required per procedure), and a growing service revenue stream through LifePort Preservation Centers in the US (Newark, Livingston, Philadelphia) and the National Kidney Preservation Service in Belgium. The company sells through a direct enterprise field sales force supported by Clinical and Technical Advisors, with a 24/7 Perfusion Helpline serving US/Canada, EMEA, France, Germany, and Latin America. Supporting infrastructure includes a GPS Remote Monitoring Portal, multi-language mobile app, and comprehensive training programs.

Organ Recovery Systems is expanding its addressable market through the LifePort Liver Transporter currently in US clinical trials (PILOT study), geographic expansion into Asia Pacific and Latin America, and country-level government contracts modeled on the Belgium National Reimbursement Program partnership won in October 2022. The company holds multiple FDA 510(k) clearances, ISO 13485:2016 certification, MDSAP certification, and CE Mark, with its clinical evidence base anchored by 10-year follow-up data published in the New England Journal of Medicine in 2025 demonstrating sustained graft survival benefits.

Name

Organ Recovery Systems

Legal name

Organ Recovery Systems, Inc.

Website

https://organ-recovery.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

Organ Recovery Systems is a privately held medical device company that develops and manufactures the LifePort platform, the leading portable hypothermic machine perfusion technology used by 98% of US OPOs to preserve and transport kidneys for transplantation, serving 400+ transplant programs in 49 countries.

Ownership category

akta.pro rank

Product category

Organ Preservation Medical Devices

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Mechanical Circulatory Support (VAD, IABP, ECMO) (HLAHAFAG)

akta.pro secondary industry

Blood, Organ & Tissue Donation Organizations (BPAGACAJ)

Keywords

• Organ preservation devices
• Kidney perfusion systems
• Transplant medical devices
• Preservation consumables
• Organ transplant services

Headquarters

HQ city

Itasca

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. LifePort Kidney Transporter Devices: Sale of portable hypothermic machine perfusion devices (LifePort Kidney Transporter) to OPOs and transplant centers. The device is a reusable capital equipment item.
2. Disposable Products: Recurring revenue from disposable products required for each perfusion case including Perfusion Circuits, Sterile Drapes, and Cannulas. These are single-use consumables replaced for each organ preservation procedure.
3. Preservation Solutions: Sale of preservation solutions including KPS-1 (Kidney Perfusion Solution) and SPS-1 (Static Preservation Solution/UW Solution). These are required for organ preservation and are consumed during each procedure.
4. LifePort Preservation Services: Organ pumping services provided at LifePort Preservation Centers (US) and National Kidney Preservation Service (Belgium). These centers provide abdominal perfusion services using LifePort technology, creating a service-based revenue model.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Organ Recovery Systems manufactures and sells the LifePort Kidney Transporter, a portable hypothermic machine perfusion (HMP) device that preserves donor kidneys during transport from recovery through transplantation. The company also sells proprietary preservation solutions (KPS-1 and SPS-1), single-use disposables (Perfusion Circuits, Sterile Drapes, Cannulas), and operates LifePort Preservation Centers providing contract perfusion services for OPOs and transplant centers worldwide.

Product overview

Organ Recovery Systems offers a comprehensive organ preservation portfolio centered on the LifePort technology platform. The core product is the LifePort Kidney Transporter (launched 2003), the first portable hypothermic machine perfusion system for kidney preservation, supported by an ecosystem of disposable products (Perfusion Circuits, Sterile Drapes, Cannulas), preservation solutions (KPS-1 and SPS-1 UW-based solutions), and services (LifePort Preservation Centers, National Kidney Preservation Service). The pipeline includes the LifePort Liver Transporter in US clinical trials. Supporting infrastructure includes a GPS Remote Monitoring Portal, LifePort Data Station, and mobile app for training and troubleshooting. The company serves over 400 transplant programs across 49 countries.

Differentiator

Problem solved

Functional benefit

Brands

• LifePort: Product family including LifePort Kidney Transporter, LifePort Liver Transporter, and related preservation devices for organ transport and perfusion.
• LifePort Kidney Transporter
• LifePort Liver Transporter
• LifePort Preservation Services
• KPS-1
• SPS-1

Products and services

• LifePort Kidney Transporter A portable hypothermic machine perfusion (HMP) device that provides continuous cold perfusion preservation for kidneys during transportation from recovery through transplantation. Features pressure-controlled pumping, ultrasonic bubble detectors, static cold storage backup, real-time data display (pressure, temperature, flow, renal resistance), and remote GPS/cellular monitoring. Weighs 45 pounds fully loaded for one-person portability. Sold to OPOs and transplant centers.
• LifePort Kidney Transporter Disposables Single-use sterile disposable products required for each kidney perfusion case, including Perfusion Circuit, Sterile Drape, and Cannulas (Universal SealRing and Straight Cannulas). Consumed per organ preservation procedure, generating recurring revenue for Organ Recovery Systems.
• KPS-1 (Kidney Perfusion Solution) UW-based machine perfusion solution used for flushing and continuous hypothermic machine perfusion of kidneys during organ removal, storage, and transportation. FDA 510(k) cleared (K022391). Required consumable for each kidney perfusion procedure.
• SPS-1 (Static Preservation Solution / UW Solution) Market-leading static preservation solution for flushing and cold storage of kidney, liver, and pancreas organs at the time of donor removal, preparation, storage, and transportation. FDA 510(k) cleared (K091656).
• LifePort Preservation Services Contract organ perfusion services utilizing LifePort technology, offered through company-operated LifePort Preservation Centers in the US (Livingston, NJ and Philadelphia, PA) and the National Kidney Preservation Service in Belgium. Provides abdominal perfusion services including anatomy review, cannulation, perfusion, monitoring, and transportation coordination for OPOs and transplant centers.

Quantifiable outcome

• ECD kidneys perfused on LifePort show 69.6% 10-year graft survival vs 60.1% with static cold storage (SCS)
• +4 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Belgium National Reimbursement ProgramcoreStrategic or Co-development Partner · 1 October 2022In October 2022, Organ Recovery Systems won the tender to provide kidney preservation services for Belgium's National Reimbursement Program for kidney transplants. Through the National Kidney Preservation Service, HMP on LifePort Kidney Transporter became the standard of care for ECD and DCD kidneys in Belgium, with over 200 procedures performed in the first year. This is a flagship national-level partnership demonstrating government validation of the technology.

Scale indicators9 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• TransMedics: TransMedics develops the Organ Care System (OCS), a normothermic machine perfusion platform for heart, lung, and liver transplantation. It is the most direct competitor to Organ Recovery Systems in the organ perfusion space, though using a different (normothermic vs hypothermic) technology approach. Public company (NASDAQ: TMDX) with multi-billion-dollar market cap.
• OrganOx: OrganOx makes the metra, a normothermic liver perfusion device that directly competes with the pipeline LifePort Liver Transporter. Acquired by Getinge in 2024, OrganOx is the most direct clinical competitor in liver machine perfusion and a meaningful threat to ORS's liver TAM expansion.
• XVIVO Perfusion: Swedish public company (STO: XVIVO) that makes the XPS lung perfusion system and is expanding into abdominal organ preservation. Closely comparable as a publicly traded, organ-preservation-focused medical device company with overlapping clinical and commercial strategies.
• Paragonix Technologies: Public company (NASDAQ: PGNX) making the SherpaPak organ transport devices for kidney, heart, and lung. While focused on improved static cold storage rather than machine perfusion, Paragonix competes directly in the organ transport and preservation workflow that ORS addresses with LifePort.
• Bridge to Life: Bridge to Life is a direct competitor to Organ Recovery Systems' preservation solutions business (KPS-1 and SPS-1). The company distributes UW-based and other preservation solutions globally, competing head-to-head with ORS's consumables franchise in the kidney, liver, and pancreas preservation market.
• Institut Georges Lopez (IGL): IGL is a French manufacturer of organ preservation solutions (IGL-1, UW solution variants) that competes directly with ORS's KPS-1 and SPS-1 product lines. Established European player with strong presence in EU transplant centers.
• Preservation Solutions: Preservation Solutions manufactures UW (University of Wisconsin) solution for static cold storage of abdominal organs, directly competing with ORS's SPS-1 product. Long-standing incumbent in the US preservation solutions market.

Broad incumbents

• Getinge: Getinge is a large Swedish medical technology company (STO: GETI B) that acquired OrganOx in 2024 to expand into organ perfusion. As a broad incumbent, Getinge offers the metra normothermic liver perfusion system alongside a larger surgical workflows, ICU, and sterile supply portfolio—an integrated offering ORS cannot match.
• Terumo: Terumo is a large Japanese medical device manufacturer (TYO: 4543) with a transplant-related product portfolio including blood component collection and apheresis systems. Operates broadly across multiple medical device categories; competes with ORS in adjacent transplant-supporting workflows rather than direct organ preservation.
• BioLife Solutions: BioLife Solutions (NASDAQ: BLFS) provides biopreservation media and storage/protocol products for cell and gene therapies, with adjacent positioning in tissue and organ preservation through products like HypoThermosol. Public, scaled biopreservation specialist with overlapping preservation science IP and customer base (transplant centers, OPOs).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCpqIRrY7ivMKGAgUo_Y_LCw
• Xx.com/ors_lifeport

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Organ Recovery Systems